中科院微生物所与康泰生物子公司共建“合成免疫学与疫苗智造北京市重点实验室”揭牌

Core Viewpoint - The establishment of the "Beijing Key Laboratory of Synthetic Immunology and Vaccine Manufacturing" marks a significant collaboration in the field of synthetic immunology and vaccine development, involving multiple companies and a research institution [1] Group 1: Laboratory Establishment - The laboratory was inaugurated recently in Beijing [1] - It is supported by the Institute of Microbiology, Chinese Academy of Sciences [1] - The laboratory is a joint effort by Kangtai Biological, its wholly-owned subsidiary Minhai Biological, and two other companies, Xinzhi Biological and Chengda Tianhe [1] Group 2: Focus Areas - The laboratory will focus on addressing key issues in synthetic immunology and vaccine manufacturing [1]